Evidence-Based Medicine and Meta-Analysis: Getting More Out of the Literature

Clinical Decision Support

Volumn , Issue , 2007, Pages 249-264

  Lau, Joseph ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882392216     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369377-8/50012-X     Document Type: Chapter

References (45)

1. Antman E.M., Lau J., Kupelnick B., Mosteller F., Chalmers T.C. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992, 268:240-248.
2. Balk E.M., Bonis P., Moskowitz H., Schmid C.H., Ioannidis J.P.A., Wang C., Lau J. Correlation of quality measures with estimates of treatment in meta-analyses of randomized trials. JAMA 2002, 287:2973-2982.
3. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Standards for reporting of diagnostic accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 2003, 326:41-44.
4. Cappelleri J.C., Ioannidis J.P.A., deFerranti S.D., Schmid C.H., Aubert M., Chalmers T.C., Lau J. Large trials versus meta-analyses of smaller trials: How do their results compare?. JAMA 1996, 276:1332-1338.
5. Cook D.J., Mulrow C.D., Haynes R.B. Systematic reviews: Synthesis of best evidence for clinical decisions. Ann Intern Med 1997, 126:376-380.
6. Cooper H., Hedges L.V. The handbook of research synthesis 1994, Russell Sage Foundation, New York.
7. Counsell C. Formulating questions and locating primary studies for inclusion in systematic reviews. Ann Intern Med 1997, 127:380-387.
8. Systematic Reviews in Health Care: Metaanalysis in context 2001, BMJ Publishing Group, London. M. Egger, G.D. Smith, D.G. Altman (Eds.).
9. Evidence-Based Medicine Working Group. Evidence-based medicine: A new approach to teaching the practice of medicine. JAMA 1992, 268:2420-2425.
10. Furukawa T.A., Streiner D.L., Hori S. Discrepancies among megatrials. J Clin Epidemiol 2000, 53:1193-1199.
11. Harris R.P., Helfand M., Woolf S.H., Lohr K.N., Mulrow C.D., Teusch S.M., Atkins D. Current methods of the U. S. Preventive Services Task Force: A review of the process. Am J Prev Med 2001, 20:21S-35S.
12. Hill C.L., LaValley M.P., Felson D.T. Discrepancy between published report and actual conduct of randomized clinical trials. J Clin Epidemiol 2002, 55:783-786.
13. Ioannidis J.P.A., Cappelleri J.C., Lau J. Issues in comparisons between meta-analyses and large trials. JAMA 1998, 279:1089-1093.
14. Ioannidis J.P.A., Haidich A.B., Pappa M., Pantazis N., Kokori S.I., Tektonidou M.G., et al. Comparisons between randomized and non-randomized evidence. JAMA 2001, 286:821-830.
15. Ioannidis J.P.A., Lau J. Systematic review of medical evidence. Brooklyn Law J 2004, 12:509-535.
16. Irwig L., Tosteson A.N.A., Gatsonis C., Lau J., Colditz G., Chalmers T.C., Mosteller F. Guidelines for meta-analyses evaluating diagnosis tests. Ann Intern Med 1994, 120:667-676.
17. Jadad A.R., Cook D.J., Jones A., Klassen T.P., Tugwell P., Moher M., Moher D. Methodology and reports of systematic reviews and meta-analyses: A comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998, 280:278-280.
18. Jordan H.S., Lau J. Linking pharmacoeconomic analyses to results of systematic review and meta-analysis. Expert Rev Pharmacoeconomics Outcomes Res 2003, 3:89-96.
19. Juni P., Witschi A., Bloch R., Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999, 282:1054-1060.
20. Lau J., Antman E.M., Jimenez-Silva J., Kupelnick B., Mosteller F., Chalmers T.C. Clinical implications of cumulative meta-analyses of randomized control trials: Acute myocardial infarction as an example. N Engl J Med 1992, 327:248-254.
21. Lau J., Ioannidis J.P.A., Schmid C.H. Quantitative synthesis in systematic reviews. Ann Intern Med 1997, 127:820-826.
22. Lau J., Ioannidis J.P.A., Schmid C.H. Summing up evidence: One answer is not always enough. Lancet 1998, 351:123-127.
23. LeLorier J., Gregoire G., Benhaddad A., Lapierre J., Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997, 337:536-542.
24. Miller E.R.3rd, Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., Guallar E. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005, 142:37-46.
25. Moher D., Jadad A.R., Nichol G., Penman M., Tugwell P., Walsh S. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists. Control Clin Trials 1995, 16(1):62-73.
26. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F., QUOROM group. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM statement. Lancet 1999, 354:1896-1900.
27. Moher D., Pham B., Klassen T.P., Schulz K.F., Berlin J.A., Jadad A.R., Liberati A. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol 2000, 53:964-972.
28. Moher D., Schulz K.F., Altman D.G. CONSORT. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Medical Research Methodology 2001, 1:2.
29. Mulrow C.D. The medical review article: state of the science. Ann Intern Med 1987, 106:485-488.
30. Normand S.T. Meta-analysis: Formulating, evaluating, combining, and reporting. Stat Med 1999, 18:321-359.
31. Sackett D.L., Rosenberg W.M., Gray J.A., Haynes R.B., Richardson W.S. Evidence based medicine: What it is and what it isn't. BMJ 1996, 312:71-72.
32. Sampson M., Barrowman N.J., Moher D., Klassen T.P., Pham B., Platt R., et al. Should meta-analysts search Embase in addition to Medline?. J Clin Epidemiol 2003, 56:943-955.
33. Schmid C.H. Exploring heterogeneity in randomized trials via meta-analysis. Drug Information J 1999, 33:211-224.
34. Schulz K.F., Chalmers I., Grimes D.A., Altman D.G. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994, 272:125-128.
35. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
36. Tang J.L., Liu J.L.Y. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol 2000, 53:477-484.
37. Tatsioni A., Zarin D.A., Aronson N., Samson D.J., Flamm C.R., Schmid C., Lau J. Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 2005, 142:1048-1055.
38. Terrin N., Schmid C.H., Lau J., Olkin I. Adjusting for publication bias in the presence of heterogeneity. Stat Med 2003, 22:2113-2126.
39. Terrin N., Schmid C.H., Lau J. Researchers cannot visually identify publication bias from funnel plots in typical-size systematic reviews. J Clin Epidemiol 2005, 58:894-901.
40. Thompson S.G., Higgins J.P.Y. How should meta-regression analyses be undertaken and interpreted?. Stat Med 2002, 21:1559-1573.
41. Thornton A., Lee P. Publication bias in meta-analysis: Its causes and consequences. J Clin Epidemiol 2000, 53:207-216.
42. The Year in Ideas New York Times Magazine 2001, Section 6, December 9.
43. Vamvakas E.C. Meta-analyses of studies of the diagnostic accuracy of laboratory tests. A review of the concepts and methods. Arch Pathol Lab Med 1998, 122:675-686.
44. Vickers A., Goyal N., Harland R., Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998, 19:159-166.
45. Villar J., Carroli G., Belizan J.M. Predictive ability of meta-analysis of randomized controlled trials. Lancet 1995, 345.